Table 1.
Characteristics of patients with COVID-19 pneumonia.
| All patients N = 88 (100%) | Non-hospitalized N = 69 (78.7%) | Hospitalized N = 19 (21.3%) | |
|---|---|---|---|
| Gender | |||
| Male | 52 (59) | 41 (59.4) | 11 (57.9) |
| Female | 36 (41) | 28 (40.6) | 8 (42.1) |
| Age (years) | |||
| Mean (years ± SD) | 52.1 (±13.5) | 49.8 (±12.9) | 60.4 (±12.1) |
| <40 | 18 (20.4) | 17 (24.6) | 1 (5.3) |
| 40–65 | 58 (66) | 43 (62.4) | 15 (78.9) |
| >65 | 12 (13.6) | 9 (13) | 3 (15.8) |
| Co-morbidities and risk factors | |||
| Asthma | 13 (14.7) | 12 (17.4) | 1 (5.2) |
| Active smoker | 7 (7.9) | 7 (10.1) | 0 (0) |
| Cancer | 3 (3.4) | 3 (4.3) | 0 (0) |
| Diabetes | 7 (7.9) | 5 (7.2) | 2 (10.5) |
| Former smoker | 5 (5.6) | 4 (5.8) | 1 (5.2) |
| Hypertension | 13 (14.7) | 7 (10.1) | 6 (31.6) |
| Immunocompromised | 2 (2.2) | 2 (2.9) | 0 (0) |
| Obesity | 4 (4.5) | 3 (4.3) | 1 (5.2) |
| Obstructive sleep apnea | 5 (5.6) | 4 (5.8) | 1 (5.2) |
| Respiratory symptoms (NYHA scale) | |||
| Dyspnea I | 19 (21.6) | 19 (27.5) | 0 (0) |
| Dyspnea II | 30 (34.1) | 27 (39.2) | 3 (15.8) |
| Dyspnea III | 36 (40.9) | 23 (33.3) | 13 (68.4) |
| Dyspnea IV | 3 (3.4) | 0 (0) | 3 (15.8) |
| ECOG performance status | |||
| •0 | 13 (14.7) | 12 (17.4) | 1 (5.2) |
| •1 | 19 (21.7) | 19 (27.5) | 0 (0) |
| •2 | 30 (34) | 27 (39.2) | 3 (15.8) |
| •3 | 25 (28.5) | 11 (15.9) | 14 (73.8) |
| •4 | 1 (1.1) | 0 (0) | 1 (5.2) |
| Radiological examination | |||
| Standard chest-X ray performed | 75 (85.2) | 56 (81.1) | 19 (100) |
| Interstitial infiltrate found on chest-X ray | 47 (53.4) | 31 (44.9) | 16 (84.2) |
| LUS performed | 25 (28.4) | 23 (33.3) | 2 (10.5) |
| Interstitial lung pattern on LUS | 14 (15.9) | 12 (17.4) | 2 (10.5) |